Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

NCT00425555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma

Interventions

DRUG: Panobinostat

Sponsor

Novartis Pharmaceuticals